Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2032015 | Advances in Medical Sciences | 2015 | 5 Pages |
Abstract
According to our results HtrA1 appeared as an immunohistochemical marker to predict behaviour of the meningioma, mainly the recurrence. Although the exact mechanisms of HtrA1 are still largely unknown, we think that further in vivo and in vitro studies explaining the molecular targets of HtrA1 would have a great importance with regard to its role as a therapeutic agent for meningioma.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry, Genetics and Molecular Biology (General)
Authors
Evrim Ãnder, Ata Türker Arıkök, Hakan Seçkin, Murat Alper,